BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 19, 2018
View Archived Issues
Fighting senescence boosts immunity
Read More
MANF rescues dopaminergic neurons in C. elegans alpha-synuclein models of Parkinson's disease
Read More
TAS-05567 selectively inhibits Syk kinase: potential treatment for autoimmune and allergic diseases
Read More
Immunity is for babies
Read More
SOM Biotech initiates phase IIa trial of repurposed drug
Read More
THX-160 shows promise in preclinical studies for acute and chronic pain
Read More
Selective PDE4D PET ligands developed to study depression and cognitive impairment
Read More
Orion Biotechnology earns grant to support development of microbicide candidate
Read More
Researchers unveil new biomarkers of treatment-free survival in CLL
Read More
Favorable review of safety data from second dose cohort in MAGE-A10 SPEAR T-cell study
Read More
Takeda and Ovid announce expansion of the clinical program for TAK-935
Read More
Topline data presented from phase III trial of tanezumab
Read More
Positive interim data presented from a phase II/III study of marzeptacog alfa
Read More
Beta cells make and secrete autoimmune peptides
Read More
Chinese phase III trial of GV-971 in Alzheimer's disease meets primary endpoint
Read More
RPL28 gene polymorphism tied to reduced survival in FOLFIRI-treated mCRC patients
Read More
KDDF grant will support evaluation of Hyleukin-7 with Keytruda in triple-negative breast cancer
Read More
Incyte studies INCB-054707 for hidradenitis suppurativa in phase II trial
Read More
Vyriad collaborates with Merck KGaA and Pfizer to study Voyager-V1 with avelumab
Read More
FDA approves Kisqali for HR-positive HER-negative advanced or metastatic breast cancer
Read More
Phase III study of subcutaneous vedolizumab in ulcerative colitis meets primary endpoint
Read More
Daiichi Sankyo and collaborator patent TNSALP inhibitors
Read More
Aquinnah Pharmaceuticals divulges TDP-43 aggregation inhibitors
Read More
Nampt inhibition with OT-82 shows promise in xenograft leukemia models
Read More
Incyte presents PD-1/PD-L1 interaction inhibitors
Read More
Global Blood Therapeutics patents EHMT2 inhibitors
Read More
Kissei Pharmaceutical synthesizes new TRPM8 antagonists
Read More